Disease modifying and anti-nociceptive effects of the bisphosphonate, zoledronic acid in a model of bone cancer pain-Reference-Cited by-同舟云学术

Disease modifying and anti-nociceptive effects of the bisphosphonate, zoledronic acid in a model of bone cancer pain

Published:2002-12 Issue:3 Volume:100 Page:219-229
ISSN:0304-3959
Container-title:Pain
language:en
Short-container-title:

Author:

Walker Katharine,Medhurst Stephen J.,Kidd Bruce L.,Glatt Markus,Bowes Mick,Patel Sadhana,McNair Kara,Kesingland Adam,Green Jonathan,Chan Otto,Fox Alyson J.,Urban Laszlo A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Anesthesiology and Pain Medicine,Neurology (clinical),Neurology

Reference33 articles.

1. The effect of a single dose of osteoprotegerin in postmenopausal women.;Bekker;J Bone Miner Res,2001

2. Phase II trial of zoledronate versus pamidronate in multiple myeloma and breast carcinoma patients with osteolytic lesions.;Berenson;Cancer,2000

3. Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases.;Berenson;Cancer,2001

4. Clinical research update: zoledronate.;Body;Cancer,1997

5. Current and future directions in medical therapy.;Body;Cancer,2000

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low molecular weight 35 kDa hyaluronan fragment HA35 in the treatment of bone metastasis pain: A case report;Medicine;2024-08-02

2. Inflammasomes, Inflammation and Neuropathic Pain;The NLRP3 Inflammasome: An Attentive Arbiter of Inflammatory Response;2024-04-02

3. Pain Management in Metastatic Bone Disease;Metastatic Bone Disease;2024

4. miR-199a-3p suppresses neuroinflammation by directly targeting MyD88 in a mouse model of bone cancer pain;Life Sciences;2023-11

5. Bone Cancer Pain, Mechanism and Treatment;Recent Advances in Bone Tumours and Osteoarthritis;2021-09-01